Cowen Financial Products LLC - Significant Ownership

Signature - Title
Erin Morrow - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Cowen Financial Products LLC.

Significant Ownership of Cowen Financial Products LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TARS Tarsus Pharmaceuticals Inc. Common Stock, $0.0001 par value per share 4.9% $98.1M 1.91M Cowen Financial Products LLC Dec 31, 2024

Schedules 13D/G Reported by Cowen Financial Products LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.